BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24923637)

  • 41. Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8(+) T-cell responses in vivo.
    Ignatius R; Mahnke K; Rivera M; Hong K; Isdell F; Steinman RM; Pope M; Stamatatos L
    Blood; 2000 Nov; 96(10):3505-13. PubMed ID: 11071648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-Priming Dendritic Cells Exacerbate Immunopathology After Ischemic Tissue Damage in the Heart.
    Forte E; Perkins B; Sintou A; Kalkat HS; Papanikolaou A; Jenkins C; Alsubaie M; Chowdhury RA; Duffy TM; Skelly DA; Branca J; Bellahcene M; Schneider MD; Harding SE; Furtado MB; Ng FS; Hasham MG; Rosenthal N; Sattler S
    Circulation; 2021 Feb; 143(8):821-836. PubMed ID: 33297741
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
    Paglia P; Chiodoni C; Rodolfo M; Colombo MP
    J Exp Med; 1996 Jan; 183(1):317-22. PubMed ID: 8551239
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myoinjury transiently activates muscle antigen-specific CD8+ T cells in lymph nodes in a mouse model.
    Liao H; Franck E; Fréret M; Adriouch S; Baba-Amer Y; Authier FJ; Boyer O; Gherardi RK
    Arthritis Rheum; 2012 Oct; 64(10):3441-51. PubMed ID: 22674045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response.
    Rossowska J; Pajtasz-Piasecka E; Szyda A; Zietara N; Duś D
    Folia Histochem Cytobiol; 2007; 45(4):349-55. PubMed ID: 18165174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
    Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
    J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of vaccine-induced primary and memory CD8(+) T-cell responses by soluble PD-1.
    Song MY; Park SH; Nam HJ; Choi DH; Sung YC
    J Immunother; 2011 Apr; 34(3):297-306. PubMed ID: 21389868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
    Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
    J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Directly transfected langerin+ dermal dendritic cells potentiate CD8+ T cell responses following intradermal plasmid DNA immunization.
    Elnekave M; Furmanov K; Nudel I; Arizon M; Clausen BE; Hovav AH
    J Immunol; 2010 Sep; 185(6):3463-71. PubMed ID: 20713888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studying interactions between dendritic cells and T cells in vivo.
    Chudnovskiy A; Pasqual G; Victora GD
    Curr Opin Immunol; 2019 Jun; 58():24-30. PubMed ID: 30884422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells.
    Wang P; Zhao P; Dong S; Xu T; He X; Chen M
    Theranostics; 2018; 8(1):223-236. PubMed ID: 29290804
    [No Abstract]   [Full Text] [Related]  

  • 54. Splenic dendritic cell subsets prime and boost CD8 T cells and are involved in the generation of effector CD8 T cells.
    Behboudi S; Moore A; Hill AV
    Cell Immunol; 2004 Mar; 228(1):15-9. PubMed ID: 15203315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a novel antigen cross-presenting cell type in spleen.
    Tan JK; Quah BJ; Griffiths KL; Periasamy P; Hey YY; O'Neill HC
    J Cell Mol Med; 2011 May; 15(5):1189-99. PubMed ID: 20477902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi.
    Ersland K; Wüthrich M; Klein BS
    Cell Host Microbe; 2010 Jun; 7(6):474-87. PubMed ID: 20542251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
    Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
    J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.
    Herrera OB; Brett S; Lechler RI
    Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
    Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
    Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
    Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
    J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.